B&K Corporation Ltd Sustainability Reports
B&K Corporation Limited is an innovative biotechnology company that develops protein therapeutics. The company primarily discovers and commercializes platelet-derived growth factor (PDGF) drugs designed for clinical wound healing and tissue repair.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG01Z10QZF7
1 reports from 2025 to 2025
Company Profile
B&K Corporation Limited is an innovative biotechnology company that develops protein therapeutics. The company primarily discovers and commercializes platelet-derived growth factor (PDGF) drugs designed for clinical wound healing and tissue repair.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
